Get the Stockscreener App
60.77
0.20%
0.12
After Hours:
61.25
0.48
+0.79%
Doximity Inc stock is traded at $60.77, with a volume of 785.27K.
It is up +0.20% in the last 24 hours and up +1.00% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$60.65
Open:
$60.77
24h Volume:
785.27K
Relative Volume:
0.34
Market Cap:
$8.32B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
60.77
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
+1.10%
1M Performance:
+1.00%
6M Performance:
+7.44%
1Y Performance:
+116.88%
1-Day Range:
$60.09
$60.99
1-Week Range:
$58.91
$61.47
52-Week Range:
$25.00
$85.21
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SAN FRANCISCO
Compare DOCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
60.77 | 11.37B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
290.41 | 47.59B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
64.49 | 11.23B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.04 | 8.16B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.83 | 6.39B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Emergence GP Partners LLC Decreases Stock Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Cerity Partners LLC Sells 4,771 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Published on: 2025-07-25 09:44:39 - Autocar Professional
Doximity Inc. Stock Analysis and ForecastFree Consultation - PrintWeekIndia
Doximity, Inc. (DOCS): A Bull Case Theory - Insider Monkey
Doximity releases free AI scribe, highlighting the sector's commoditization - Axios
As ambient scribes face off, Doximity lures doctors with a free option - statnews.com
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Los Angeles Capital Management LLC - MarketBeat
Doximity's Premium Valuation: A Strategic Entry Point or a Cautionary Tale? - AInvest
Doximity: Slowing Sales And EBITDA Growth (NYSE:DOCS) - Seeking Alpha
Doximity Insiders Sell US$62m Of Stock, Possibly Signalling Caution - simplywall.st
Doximity (DOCS) Upgraded to Strong Buy: Here's Why - Yahoo Finance
What analysts say about Doximity Inc. stockConsistent triple returns - Autocar Professional
Wells Fargo maintains Equal Weight rating on Doximity stock amid pharma ad trends - Investing.com Australia
Y Intercept Hong Kong Ltd Makes New $2.22 Million Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
What drives Doximity Inc. stock priceMarket-leading capital gains - Autocar Professional
Doximity (NASDAQ:DOCS) Shares Down 3.7%Should You Sell? - MarketBeat
Doximity (DOCS) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Nisa Investment Advisors LLC Lowers Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity Rides on Telehealth Demand: Will This Drive Sales Further? - MSN
Edgestream Partners L.P. Acquires New Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Given New $61.00 Price Target at Truist Financial - MarketBeat
Dakota Wealth Management Purchases New Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Woodward Diversified Capital LLC Makes New $860,000 Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Is Doximity Inc. a good long term investmentFree Capital Efficiency Planning - Autocar Professional
Doximity’s SWOT analysis: digital health leader’s stock faces growth challenges By Investing.com - Investing.com South Africa
Doximity’s SWOT analysis: digital health leader’s stock faces growth challenges - Investing.com Nigeria
Doximity, Inc. (NASDAQ:DOCS) Receives $64.42 Consensus Target Price from Brokerages - MarketBeat
Doximity Poll: Yale Psychiatry Residency Program Ranks #3 Nationally - Yale School of Medicine
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.76%
3.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):